Delta4 is a Vienna-based biotech startup driving the forefront of digital drug discovery and development. Delta4 leverages on a proprietary computational analytics platform (e.valuation), combined with straightforward biomedical testing and clinical validation of candidate drugs.

Our unique approach integrates iterative big data/in silico and experimental screens, offering the most efficient matching of clinical indications and compound/drug effect.

Our R&D process allows a fast track to clinical stage testing. Delta4’s methodological core is tailored toward precision to increase the probability of success.

The original EU-India Innocenter project received funding from the European Union's Horizon 2020
Coordination and Support Action Program under Grant Agreement No. 101004815 and was created with love by: